Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1986-12-22
1988-04-05
Hollrah, Glennon H.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514256, 514314, 514414, 514422, 544333, 546167, 546281, 548466, 548527, A61K 31395, A61K 3144, C07D40514
Patent
active
047359587
ABSTRACT:
Certain trans-6-[2-[2-(substituted-phenyl)-3- (or 4-)heteroaryl-5-substituted-1H-pyrrol-1-yl]ethyl]tetrahydro-4-hydroxy-2H-p yran-2-ones and the corresponding lactone-ring-opened acids are potent inhibitors of the enzyme 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMG CoA reductase) and are thus useful hypolipidemic or hypocholesterolemic agents. Pharmaceutical compositions containing such compounds, and a method of inhibiting the biosynthesis of cholesterol employing such pharmaceutical compositions are also disclosed.
REFERENCES:
patent: 4613610 (1986-09-01), Wareing
patent: 4647576 (1987-03-01), Hoefle et al.
Roth Bruce D.
Sliskovic Drago R.
Hollrah Glennon H.
Janssen Jerry F.
Turnipseed James H.
Warner-Lambert & Company
LandOfFree
Trans-6-[2-[2-(substituted-phenyl)-3- (or 4-) heteroaryl-5-subst does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Trans-6-[2-[2-(substituted-phenyl)-3- (or 4-) heteroaryl-5-subst, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Trans-6-[2-[2-(substituted-phenyl)-3- (or 4-) heteroaryl-5-subst will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2233847